What are Medifast's profit margins?

Medifast (MED) runs a 70.1% gross margin and a -4.7% operating margin, with a -5.8% net margin.

Where do Medifast's ratios come from?

Every ratio is computed from Medifast's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Medifast MED Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	70.1%-1.2pp	71.3%-1.1pp	72.4%-1.4pp	73.8%0.0pp	73.9%+0.1pp
Operating margin	-4.7%-1.0pp	-3.7%-2.4pp	-1.3%-1.4pp	0.1%+1.3pp	-1.2%-1.6pp
Net margin	-5.8%-0.9pp	-4.8%-4.9pp	0.1%-0.7pp	0.8%+2.0pp	-1.3%-1.6pp
Returns
Return on equity	-9.8%-0.7pp	-9.1%-9.2pp	0.1%-1.6pp	1.7%+5.0pp	-3.3%-4.3pp
Return on invested capital	-11.8%-0.6pp	-11.1%-8.7pp	-2.4%-2.6pp	0.2%+5.0pp	-4.7%-5.9pp
Efficiency
Asset turnover	1.3×-0.1×	1.4×-0.1×	1.5×-0.2×	1.7×-0.2×	1.9×-0.2×
Liquidity
Current ratio	4.8×+0.1×	4.7×+0.2×	4.4×0.0×	4.5×+0.9×	3.5×+0.2×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$17.96-0.8%	$18.11-7.3%	$19.530.0%	$19.53+1.4%	$19.27+0.5%
Valuation
Market capitalization	$121.87M-17.4%	$117.39M-21.9%	$150.25M-0.2%	$150.58M+2.1%	$147.44M-23.5%
Price / sales	0.4×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Price / book	0.6×-0.1×	0.6×-0.1×	0.7×0.0×	0.7×0.0×	0.7×-0.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Medifast.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Medifast's profit margins?: Medifast (MED) runs a 70.1% gross margin and a -4.7% operating margin, with a -5.8% net margin.
Where do Medifast's ratios come from?: Every ratio is computed from Medifast's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.